← Back to headlines
India Approves First Dengue Vaccine, Qdenga
India has approved its first dengue vaccine, Qdenga by Takeda, for individuals aged 4 to 60, following clearance from the DCGI. This marks a significant step in the country's efforts to combat dengue fever.
20 Jul, 07:31 — 20 Jul, 09:26
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
indian-express
Center
Right1
Right (1)
Times of India
Far R
Geographic diversity— 1 region4/34
India2
ℹAll sources from India region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
Times of IndiaMostly Factual2d ago
India approves its first dengue vaccine QDENGA after DCGI clearance
Dengue is a mosquito-borne viral disease reported in more than 125 countries. According to the company, India accounts for nearly one-third of the global dengue burden, with rapid urbanisation, climate change and widespread mosquito breeding continuing to increase the risk of infection across the country. Vaccine QDENGA is given as two injections of 0.5 ml, administered under the skin three months apart.
By TOI NEWS DESK
Read full article →indian-expressMostly Factual2d ago
India’s first dengue vaccine approved: DCGI clears Takeda’s Qdenga for those aged 4 to 60
By Anuradha Mascarenhas
Read full article →Coverage Timeline
First report: Times of India · 20 Jul, 07:31|Full coverage: 2 · 2h|Window: 2h
Left-leaningCenterRight-leaning
